Spirulina (Arthrospira platensis)
What Is Spirulina?
Spirulina is catalogued in the Materia Medica under the binomial Arthrospira platensis, a alga of the Microcoleaceae family, native to the alkaline lakes of Africa and Central America. The material in circulation is whole cyanobacterium — the whole plant, used without separating the parts. Most people search for it simply as Spirulina; suppliers, pharmacopoeias and interaction databases list it as Arthrospira platensis, and matching the two is the first step in identifying what is actually in a product. In the hand it reads as deep grassy, marine, faintly sulfurous — a practical marker of freshness and correct identification.
The written history of Spirulina begins with household and practitioner use — recipes, harvesting notes and cautions passed between regions — and only much later with laboratory description of what the whole cyanobacterium contains. Beyond its practical use it carries cultural associations — aztec 'tecuitlatl' — harvested from Lake Texcoco.
Today most searches for Spirulina come from people reading about seasonal allergies, cholesterol and weight management, or checking how it sits alongside a medication they already take. The use most often documented in the literature is Reduces LDL and triglycerides in dyslipidemia, followed by improves allergic rhinitis (phycocyanin).
How Does Spirulina Work?
Spirulina works as a mixture rather than a single isolated compound, and its profile is usually described by the class of constituents present in whole cyanobacterium rather than by one marker molecule.
The older understanding of Spirulina is procedural rather than molecular — which part to take, in what season, and in what medium — and modern constituent work has largely been an attempt to explain why those procedures were chosen.
The research base is developing: there are human trials, though sample sizes and designs vary, and this profile cites 1 source. Reported findings centre on contains phycocyanin, β-carotene, GLA, complete amino acid profile. Where research exists, it examines Reduces LDL and triglycerides in dyslipidemia, improves allergic rhinitis (phycocyanin) and iron repletion (RCT-supported). These are areas of study, not established outcomes, and results differ by preparation and dose.
How the plant is prepared changes what you actually get. Its constituents move readily into water and alcohol — so a preparation made in another medium will not carry the same fraction of the plant, which is why traditional recipes specify one over another.
What makes Spirulina distinct is the combination rather than any one molecule: the same compound classes appear in other botanicals, but their ratio here — and the whole cyanobacterium they are drawn from — is what the traditional and research literature both describe.
Because these constituents are processed by the same pathways that handle many medicines, Spirulina is documented as interacting with immunosuppressants. That is a question of shared metabolism rather than of potency, and it is the main reason the plant is listed in interaction references at all.
Dose, plant part and growing conditions all shift the constituent profile, so two products carrying the name Spirulina can differ substantially; this is why reference entries specify whole cyanobacterium and, where they exist, standardisation markers.